On Thursday, genetics-led consumer healthcare company 23andMe Holding Co. (NASDAQ:ME) announced a business restructuring to ...

23andMe, a popular South San Francisco-based genetic testing company, is laying off 40% of its workers after struggling with ...

Concerns about 23andMe's business prospects is raising questions about the genetic testing company's customer data.

The struggling genetic testing company 23andMe says it will cut 40% of its workforce, or 200 jobs, as it fights for ...

NEW YORK — 23andMe is laying off 40% of its workforce, or more than 200 employees, and discontinuing its therapeutics ...

The financial struggles of genetic testing and ancestry company 23andMe are raising questions about the security of customers ...

The once-high-flying firm has been beset by challenges since going public via a SPAC merger in 2021. Here’s the latest.

Jessica Ko saw others sharing their DNA results online and decided to take a test. The results have changed how she sees ...

CEO Eric Lefkofsky said the purchase of Ambry Genetics will expand Tempus’ testing portfolio and bring in a fast-growing ...

In this photo illustration, a 23andMe logo seen displayed on a smartphone and in the background. The company announced Monday ...

DNA commodification is no longer a future concern; it’s a present reality. Beyond charging users for their services, some ...